Tyrosine kinase inhibitor treatment for renal cell carcinoma with inferior vena cava tumour thrombus: a quantitative summary

被引:7
作者
Klatte, Tobias [1 ,5 ]
Welsh, Sarah J. J. [2 ,3 ]
Riddick, Antony C. P. [3 ]
Karam, Jose A. [4 ]
Stewart, Grant D. D. [2 ,3 ]
机构
[1] Charite Univ Med Berlin, Berlin, Germany
[2] Univ Cambridge, Cambridge, England
[3] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[5] Charite Univ Med Berlin, Dept Urol, Charitepl 1, D-10117 Berlin, Germany
基金
英国工程与自然科学研究理事会;
关键词
neoadjuvant; thrombus; systemic treatment; tyrosine kinase inhibitor; cava thrombus; TARGETED MOLECULAR THERAPY; PRESURGICAL TREATMENT; EXPERIENCE; MANAGEMENT; SUNITINIB;
D O I
10.1111/bju.15966
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:566 / 568
页数:3
相关论文
共 14 条
[1]  
[Anonymous], GRADE handbook
[2]   Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful? [J].
Bigot, Pierre ;
Fardoun, Tarek ;
Bernhard, Jean Christophe ;
Xylinas, Evanguelos ;
Berger, Julien ;
Roupret, Morgan ;
Beauval, Jean-Baptiste ;
Lagabrielle, Samuel ;
Lebdai, Souhil ;
Ammi, Myriam ;
Baumert, Herve ;
Escudier, Bernard ;
Grenier, Nicolas ;
Hetet, Jean-Francois ;
Long, Jean-Alexandre ;
Paparel, Philippe ;
Rioux-Leclercq, Nathalie ;
Soulie, Michel ;
Azzouzi, Abdel-Rahmene ;
Bensalah, Karim ;
Patard, Jean-Jacques .
WORLD JOURNAL OF UROLOGY, 2014, 32 (01) :109-114
[3]   The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus [J].
Blute, ML ;
Leibovich, BC ;
Lohse, CM ;
Cheville, JC ;
Zincke, H .
BJU INTERNATIONAL, 2004, 94 (01) :33-41
[4]   The Impact of Targeted Molecular Therapies on the Level of Renal Cell Carcinoma Vena Caval Tumor Thrombus [J].
Cost, Nicholas G. ;
Delacroix, Scott E., Jr. ;
Sleeper, Joshua P. ;
Smith, Paul J. ;
Youssef, Ramy F. ;
Chapin, Brian F. ;
Karam, Jose A. ;
Culp, Stephen ;
Abel, E. Jason ;
Brugarolas, James ;
Raj, Ganesh V. ;
Sagalowsky, Arthur I. ;
Wood, Christopher G. ;
Margulis, Vitaly .
EUROPEAN UROLOGY, 2011, 59 (06) :912-918
[5]   Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative Analysis [J].
Field, Charles A. ;
Cotta, Brittney H. ;
Jimenez, Juan ;
Lane, Brian R. ;
Yim, Kendrick ;
Lee, Hak J. ;
Ryan, Stephen T. ;
Hamilton, Zachary A. ;
Patel, Sunil ;
Wang, Song ;
Kane, Christokher J. ;
Dey, Sumi ;
Mckay, Rana R. ;
Noyes, Sabrina ;
Millard, Frederick E. ;
Rini, Brian, I ;
Campbell, Steven C. ;
Derweesh, Ithaar H. .
CLINICAL GENITOURINARY CANCER, 2019, 17 (03) :E505-E512
[6]   Limited benefit of targeted molecular therapy for inferior vena cava thrombus associated with renal cell carcinoma [J].
Fukuda, Hironori ;
Kondo, Tsunenori ;
Takagi, Toshio ;
Iizuka, Jumpei ;
Nagashima, Yoji ;
Tanabe, Kazunari .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (04) :767-773
[7]  
Horn T, 2012, ANTICANCER RES, V32, P1729
[8]   Experience with management of renal cell carcinoma with inferior vena cava/right atrial tumor thrombus [J].
Kakoti, Shitangsu ;
Jena, Rahul ;
Sureka, Sanjoy Kumar ;
Srivastava, Aneesh ;
Mandhanil, Anil ;
Singh, Uday Pratap .
INDIAN JOURNAL OF UROLOGY, 2021, 37 (03) :234-240
[9]   A critical analysis of surgery for kidney cancer with vena cava invasion [J].
Kirkali, Ziya ;
Van Poppel, Hein .
EUROPEAN UROLOGY, 2007, 52 (03) :658-662
[10]   Role of presurgical targeted molecular therapy in renal cell carcinoma with an inferior vena cava tumor thrombus [J].
Peng, Cheng ;
Gu, Liangyou ;
Wang, Lei ;
Huang, Qingbo ;
Wang, Baojun ;
Guo, Gang ;
Fan, Yang ;
Gao, Yu ;
Ma, Xin ;
Zhang, Xu .
ONCOTARGETS AND THERAPY, 2018, 11 :1997-2005